Expression of ESBL, MBL and AmpC β lactamases by extra intestinal Escherichia coli isolates: correlation with treatment and clinical outcome

Journal Title: Journal of Microbiology and Infectious Diseases - Year 2013, Vol 3, Issue 4

Abstract

Objective: We investigated the expression of Extended Spectrum β-Lactamases (ESBLs), AmpC β lactamases and Carbapenemases in extraintestinal pathogenic Escherichia coli (ExPEC) isolates and correlated with treatment and outcome of the patients. Methods: Three hundred ExPEC infected patients were included in the study. Demographic data, antibiogram, treatment and outcome were collected. Production of ESBLs was detected by combination disk method; AmpC was detected by AmpC disk test. Carbapenemase production was detected by disk diffusion and confirmed by modified Hodge test. Identification of metallo- β-lactamase (MBL) activity was performed by the carbapenem-EDTA combined disk method and MBL E-test. Results: Out of 300 E. coli isolates, 212 (71%) were ESBL producers. AmpC β lactamase production was seen in 95 (32%) isolates; 16 (17%) isolates were pure AmpC producers whereas 79 (83%) were ESBL co-producers. Twenty nine (9.5%) isolates were carbapenemase producers of which 15 (5%) were MBL producers. For treatment, most widely prescribed antibiotics were β-lactam+β-lactamase inhibitor combinations (39%). Sixty seven percent patients improved; relapse/re-infection was seen in 18% of patients and 11% patients expired. Increased mortality was seen in patients with blood stream infection and more number of relapses was seen in urinary tract infection. Conclusion: ExPEC producing ESBL or AmpC along with carbapenemases are particularly challenging for clinicians and are a major threat worldwide. Early use of appropriate antibiotics like β-lactam+β-lactamase inhibitor combinations will probably reduce complications in these patients. Key words: AmpC, ExPEC, ESBL, MBL, J Microbiol Infect Dis 2013;3(4): 150-156

Authors and Affiliations

Arindam Chakraborty, Prabha Adhikari, Shalini Shenoy, Shrikala Baliga, Satish Rao, Dhanashree Biranthabail, Vishwas Saralaya

Keywords

Related Articles

Genişlemiş spektrumlu beta-laktamaz üreten E. coli suşlarının moleküler epidemiyolojisi

Amaç: Escherichia coli O25b-ST131 dünyanın her tarafında hastanelerde ve toplumda yaygındır. Bu çalışmanın amacı bu bölgedeki farklı kaynaklardan alınan klinik örneklerde genişlemiş spektrumlu beta-laktamaz üreten E. col...

Anti-nükleer antikor test sonuçlarının klinik uygulamada değerlendirilmesi

Amaç: Bu çalışmanın amacı 2009-2011 yıllarında laboratuvarımızda yapılan ANA (antinükleer antikor) tetkik sonuçlarının retrospektif olarak değerlendirilmesidir. Yöntemler: Bu dönemde laboratuvarımızda toplam 5068 serum...

Diagnostic value of Cobas Amplicor MTB and Rotorgene Real Time PCR for tuberculous meningitis: A six-year retrospective study

Objective: Tuberculous meningitis (TBM) is the most severe and lethal form of tuberculosis (TB).Bacteriologic confirmation of TBM is difficult and slow. Therefore, most patients receive antituberculosis treatment based o...

Frequency of Carbapenemase Producing Klebsiella pneumoniae in Makkah, Saudi Arabia

Objective: Carbapenemase producing Klebsiella pneumoniae is emerging as an important pathogen worldwide which has alarming clinical threat with serious effects on patients outcome. The aim of our study is to determine pr...

Telaprevir-related DRESS syndrome complicating hepatitis C treatment

In chronic hepatitis C patients telaprevir attracts attention with high sustained virologic response and short term treatment however it is associated a new spectrum of adverse events, especially several cutaneous manif...

Download PDF file
  • EP ID EP151931
  • DOI 10.5799/ahinjs.02.2013.04.0100
  • Views 73
  • Downloads 0

How To Cite

Arindam Chakraborty, Prabha Adhikari, Shalini Shenoy, Shrikala Baliga, Satish Rao, Dhanashree Biranthabail, Vishwas Saralaya (2013). Expression of ESBL, MBL and AmpC β lactamases by extra intestinal Escherichia coli isolates: correlation with treatment and clinical outcome. Journal of Microbiology and Infectious Diseases, 3(4), 150-156. https://europub.co.uk/articles/-A-151931